Incorporation of 10-Hydroxycamptothecin (cas 19685-09-7) nanocrystals into zein microspheres
-
Add time:09/04/2019 Source:sciencedirect.com
Incorporation of drug nanocrystal (DNC) into a particulate carrier to form the DNC delivery system was conducted in this study, where 10-Hydroxycamptothecin (cas 19685-09-7) (HCPT) was selected as the model drug and zein was the carrier. The supercritical anti-solvent (SAS) process or the built-in ultrasonic dialysis process (BUDP) was applied to prepare HCPT NC-loaded zein microspheres (HCPT NC-Zein MS) at first respectively, but the results showed that the products obtained were unsatisfactory in their particle microstructures. Fortunately, by combining the SAS process with BUDP, i.e. the co-precipitation of HCPT and zein prepared using the SAS process was dispersed into ethanol–water as the dialysis solution for BUDP, the results showed that desirable HCPT NC-Zein MS were obtained. The formulations were evaluated quantitatively by an overall desirability function (DF), and the optimized HCPT NC- Zein MS was prepared according to the range analysis results of DF. Under the optimized conditions, HCPT NC-Zein MS with a mean particle size=1.10±0.12 µm, drug loading=5.98% and encapsulation efficiency=95.68% were obtained. The further characterizations of SEM, FT-IR, XRD and DSC demonstrated that HCPT NC was successfully incorporated into the interior of zein microspheres. The effects of the process parameters and the formation mechanism of HCPT NC-Zein MS were discussed in detail. Furthermore, it is presented that HCPT NC-Zein MS sustained HCPT release rate successfully, where about 50% HCPT was fast released in the first 20 h, then the release trend followed zero order kinetics and reached 70% in 82 h.
We also recommend Trading Suppliers and Manufacturers of 10-Hydroxycamptothecin (cas 19685-09-7). Pls Click Website Link as below: cas 19685-09-7 suppliers
Prev:Monodisperse oligoethylene glycols modified Camptothecin, 10-Hydroxycamptothecin (cas 19685-09-7) and SN38 prodrugs
Next:Review articleAntibody-drug conjugates of 7-ethyl-10-Hydroxycamptothecin (cas 19685-09-7): Sacituzumab govitecan and labetuzumab govitecan) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original articleStudy the voltammetric behavior of 10-Hydroxycamptothecin (cas 19685-09-7) and its sensitive determination at electrochemically reduced graphene oxide modified glassy carbon electrode09/08/2019
- Full Length ArticleIn vitro and in vivo evaluation of 10-Hydroxycamptothecin (cas 19685-09-7)-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization09/07/2019
- An efficient approach for the enzyme-enhanced extraction of camptothecin and 10-Hydroxycamptothecin (cas 19685-09-7) from the samara of Camptotheca acuminata using an ionic liquid solution09/06/2019
- Review articleAntibody-drug conjugates of 7-ethyl-10-Hydroxycamptothecin (cas 19685-09-7): Sacituzumab govitecan and labetuzumab govitecan09/05/2019
- Monodisperse oligoethylene glycols modified Camptothecin, 10-Hydroxycamptothecin (cas 19685-09-7) and SN38 prodrugs09/03/2019
- ORIGINAL ARTICLEMenthol-modified casein nanoparticles loading 10-Hydroxycamptothecin (cas 19685-09-7) for glioma targeting therapy09/02/2019
- Full Length ArticleSelf-assembly behavior of amphiphilic poly(ethylene glycol)-conjugated 10-Hydroxycamptothecin (cas 19685-09-7) in water and its cytotoxicity assay09/01/2019
- Enzyme/pH dual-responsive polymer prodrug nanoparticles based on 10-Hydroxycamptothecin (cas 19685-09-7)-carboxymethylchitosan for enhanced drug stability and anticancer efficacy08/31/2019
-
Health and Chemical more >
-
Related Products


